How much should you hold?
- Overall Portfolio exposure to Amanta Healthcar should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
-2.00%
EBIT Growth (5y)
9.30%
EBIT to Interest (avg)
1.30
Debt to EBITDA (avg)
3.27
Net Debt to Equity (avg)
1.99
Sales to Capital Employed (avg)
0.80
Tax Ratio
28.62%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.34%
ROCE (avg)
13.97%
ROE (avg)
8.18%
Valuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
31
Price to Book Value
2.01
EV to EBIT
12.30
EV to EBITDA
8.50
EV to Capital Employed
1.73
EV to Sales
1.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.03%
ROE (Latest)
4.98%
Loading Valuation Snapshot...
6What is working for the Company
PAT(9M)
At Rs 10.75 cr has Grown at 73.88%
OPERATING PROFIT TO INTEREST(Q)
Highest at 3.04 times
NET SALES(Q)
Highest at Rs 74.49 cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Amanta Healthcar
Profit After Tax (PAT) - Nine Monthly
At Rs 10.75 cr has Grown at 73.88%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 3.04 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales - Quarterly
Highest at Rs 74.49 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)